Stock listing
Vera Therapeutics, Inc.
Selected listing: VERA · NASDAQ · USD · US
Vera Therapeutics, Inc. (NASDAQ:VERA), Health Technology. Latest release Oct 2, 2026: Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule…
- Ticker
- NASDAQ:VERA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Vera Therapeutics, Inc.
Vera Therapeutics, Inc. (VERA) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Vera Therapeutics, Inc.
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026
Vera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Will be A Featured Late-breaking Oral Presentation at the Opening Plenary Session of ASN Kidney Week 2026
October 2, 2026
Vera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Will be A Featured Late-breaking Oral Presentation at the Opening Plenary Session of ASN Kidney Week 2026
October 1, 2026
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2026
Vera Therapeutics Announces TRUTAKNA Stabilized eGFR and Prevented Kidney Disease Progression through Two Years in ORIGIN 3 Final Efficacy Analysis in IgA Nephropathy
September 16, 2026
Research Vera Therapeutics, Inc.
Vera Therapeutics, Inc. company profile
View the public company page for Vera Therapeutics, Inc. on 6ix.
Vera Therapeutics, Inc. news
Read company news and market updates connected to Vera Therapeutics, Inc..
Vera Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Vera Therapeutics, Inc..